St. Michael's Hospital, Keenan Research Centre, Li Ka Shing Knowledge Institute, Toronto, Canada.
Department of Physiology, University of Toronto, Toronto, Canada.
PLoS One. 2021 Jun 24;16(6):e0252711. doi: 10.1371/journal.pone.0252711. eCollection 2021.
Patients with diabetes are at a high risk for developing cardiac dysfunction in the absence of coronary artery disease or hypertension, a condition known as diabetic cardiomyopathy. Contributing to heart failure is the presence of diabetic kidney disease. The Goto-Kakizaki (GK) rat is a non-obese, non-hypertensive model of type 2 diabetes that, like humans, shares a susceptibility locus on chromosome 10. Herein, we perform a detailed analysis of cardio-renal remodeling and response to renin angiotensin system blockade in GK rats to ascertain the validity of this model for further insights into disease pathogenesis.
Study 1: Male GK rats along with age matched Wistar control animals underwent longitudinal assessment of cardiac and renal function for 32 weeks (total age 48 weeks). Animals underwent regular echocardiography every 4 weeks and at sacrifice, early (24 weeks) and late (48 weeks) timepoints, along with pressure volume loop analysis. Histological and molecular characteristics were determined using standard techniques. Study 2: the effect of renin angiotensin system (RAS) blockade upon cardiac and renal function was assessed in GK rats. Finally, proteomic studies were conducted in vivo and in vitro to identify novel pathways involved in remodeling responses.
GK rats developed hyperglycaemia by 12 weeks of age (p<0.01 c/w Wistar controls). Echocardiographic assessment of cardiac function demonstrated preserved systolic function by 48 weeks of age. Invasive studies demonstrated left ventricular hypertrophy, pulmonary congestion and impaired diastolic function. Renal function was preserved with evidence of hyperfiltration. Cardiac histological analysis demonstrated myocyte hypertrophy (p<0.05) with evidence of significant interstitial fibrosis (p<0.05). RT qPCR demonstrated activation of the fetal gene program, consistent with cellular hypertrophy. RAS blockade resulted in a reduction blood pressure(P<0.05) cardiac interstitial fibrosis (p<0.05) and activation of fetal gene program. No significant change on either systolic or diastolic function was observed, along with minimal impact upon renal structure or function. Proteomic studies demonstrated significant changes in proteins involved in oxidative phosp4horylation, mitochondrial dysfunction, beta-oxidation, and PI3K/Akt signalling (all p<0.05). Further, similar changes were observed in both LV samples from GK rats and H9C2 cells incubated in high glucose media.
By 48 weeks of age, the diabetic GK rat demonstrates evidence of preserved systolic function and impaired relaxation, along with cardiac hypertrophy, in the presence of hyperfiltration and elevated protein excretion. These findings suggest the GK rat demonstrates some, but not all features of diabetes induced "cardiorenal" syndrome. This has implications for the use of this model to assess preclinical strategies to treat cardiorenal disease.
患有糖尿病的患者在没有冠状动脉疾病或高血压的情况下,存在心脏功能障碍的高风险,这种情况被称为糖尿病心肌病。导致心力衰竭的是糖尿病肾病的存在。Goto-Kakizaki(GK)大鼠是一种非肥胖、非高血压的 2 型糖尿病模型,与人类一样,在第 10 号染色体上存在一个易感性位点。在此,我们对 GK 大鼠的心脏-肾脏重塑和肾素-血管紧张素系统阻断的反应进行了详细分析,以确定该模型是否适合进一步深入了解疾病发病机制。
研究 1:雄性 GK 大鼠与年龄匹配的 Wistar 对照动物一起接受了 32 周的心脏和肾功能的纵向评估(总年龄 48 周)。动物每 4 周进行一次常规超声心动图检查,在 24 周(早期)和 48 周(晚期)时进行心脏压力-容积环分析。使用标准技术确定组织学和分子特征。研究 2:评估了肾素-血管紧张素系统(RAS)阻断对 GK 大鼠心脏和肾功能的影响。最后,在体内和体外进行蛋白质组学研究,以确定重塑反应涉及的新途径。
GK 大鼠在 12 周龄时出现高血糖(p<0.01,与 Wistar 对照组相比)。48 周龄时,心脏功能的超声心动图评估显示收缩功能正常。侵入性研究表明左心室肥厚、肺充血和舒张功能障碍。肾功能正常,表现为超滤。心脏组织学分析显示肌细胞肥大(p<0.05),有明显的间质纤维化(p<0.05)。RT-qPCR 显示胎儿基因程序的激活,与细胞肥大一致。RAS 阻断导致血压降低(p<0.05)、心脏间质纤维化减少(p<0.05)和胎儿基因程序的激活。在观察到收缩或舒张功能无明显变化的情况下,对肾脏结构或功能的影响也很小。蛋白质组学研究表明,参与氧化磷酸化、线粒体功能障碍、β-氧化和 PI3K/Akt 信号通路的蛋白质发生了显著变化(均 p<0.05)。此外,在 GK 大鼠的 LV 样本和在高葡萄糖培养基中孵育的 H9C2 细胞中均观察到类似的变化。
到 48 周龄时,糖尿病 GK 大鼠表现出收缩功能正常和舒张功能障碍的证据,同时伴有左心室肥厚、超滤和蛋白尿升高。这些发现表明,GK 大鼠表现出一些,但不是所有的糖尿病诱导的“心肾”综合征特征。这对使用该模型评估治疗心肾疾病的临床前策略具有重要意义。